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The role of the familial cancer clinic (FCC) is to provide
a cancer risk assessment and appropriate cancer risk
management advice, but there are certain groups of
patients for whom there are no standard risk manage-
ment guidelines. One such group is women with a
strong family history of breast cancer but BRCA genetic
testing has not found a germline mutation. As a family
history of breast cancer is the commonest reason for
referral to FCCs, this clinical scenario is a frequent chal-
lenge to us all.
This presentation will provide a summary of the litera-
ture surrounding:
￿ Breast cancer risk in BRCAX families
￿ Ovarian cancer risk in BRCAX families
￿ Does the presence of male breast cancer affect the
breast and ovarian cancer risks for women in BRCAX
families
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